Johnson & Johnson (JNJ) – General News
-
Medical device makers see limited hit from weight-loss drugs
-
Stock Market Today: Dow ekes out gain, but rising Treasury yields stifle upside
-
S&P 500 falls as Nvidia slip, rising yields overshaddow quarterly earnings
-
Bank of America reports, Johnson&Johnson, retail sales: 3 things to watch
-
J&J to hold 9.5% stake in Kenvue after share exchange offer
-
Stock market today: Dow wraps up second monthly gain in July as energy jumps
-
S&P 500 stutters on final day of trade for July
-
J&J shares on track for biggest daily drop in 3 years on talc setback
-
U.S. stocks are mixed after Tesla, Netflix earnings
-
J&J sues in latest bid to halt Medicare drug price negotiations
-
S&P 500 wobbles as PacWest-led slump in banks stokes worries; Apple earnings eyed
-
Cancer victims urge US judge to dismiss J&J talc unit second bankruptcy
-
Dow futures slide lower as investors digest earnings
-
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.03%
-
Beige book, Tesla earnings, Morgan Stanley: 3 things to watch
-
S&P 500 struggles for direction as investors weigh mixed quarterly results
-
U.S. stocks are mixed, as Bank of America, J&J earnings lift S&P 500
-
Dow futures rise 135 pts; Bank of America earnings boost sentiment
-
Netflix reports, Johnson&Johnson, bank earnings: 3 things to watch
-
Dow futures little changed as investors await corporate earnings
-
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.24%
-
Stock market today: Dow ends higher on healthcare climb, but tech wreck persists
-
Midday movers: Johnson&Johnson, Conagra, FedEx and more
-
U.S. stocks were mixed after weaker-than-expected jobs data
-
Johnson&Johnson, FedEx and ConAgra Foods rise premarket; UBS falls
-
J&J rises as $9 billion talc lawsuit settlement eases overhang on unit spinoff
-
J&J unit files for second bankruptcy to pursue $8.9 billion talc settlement
-
Exclusive-Johnson & Johnson considers refiling talc-liability bankruptcy after appeals-court defeat
-
J&J bows out of RSV vaccine race after scrapping trial
-
J&J to seek U.S. Supreme Court review on unit's bankruptcy
-
Alcon to pay Johnson & Johnson $199 million to settle eye-laser cases
-
Johnson & Johnson shares tumble on reports talc unit bankruptcy case dismissed by appeals court
-
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.34%
-
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.40%
-
Top 5 stocks to end the year, according to Artificial Intelligence
-
Midday Movers: Uber Technologies, Intuit, Abiomed and More
-
Uber, Pfizer, Tesla, Carvana Rise Premarket; Eli Lilly Falls
-
J&J to buy heart pump maker Abiomed for $16.6 billion ahead of consumer health spinoff
-
Netflix&Goldman Earnings, Industrial Output, BoE QT - What's Moving Markets
-
GSK: Trials for Respiratory Virus Vaccine "Positive"
-
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.66%
-
J&J names consumer health business Kenvue ahead of spin-off
-
J&J booster 85% effective against Omicron hospitalisation, S.Africa says
-
J&J says its single dose protects against breakthrough COVID-19 for up to 6 months
-
J&J sees potential for 14 new multibillion-dollar drugs by 2025
-
Reactions to J&J's plans to split into two companies
-
Factbox-J&J's legal liabilities as it plans to split
-
J&J to spin off consumer products and focus on pharmaceuticals
-
U.S. judge temporarily halts Johnson & Johnson talc cases, moves them to New Jersey
-
U.S. FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost
Back to JNJ Stock Lookup
